San Raffaele Telethon Institute for Gene Therapy, San Raffaele Scientific Institute, Milan, Italy.
Blood. 2009 Dec 10;114(25):5152-61. doi: 10.1182/blood-2009-04-214569.
We previously showed that incorporating target sequences for the hematopoietic-specific microRNA miR-142 into an antigen-encoding transgene prevents antigen expression in antigen-presenting cells (APCs). To determine whether this approach induces immunologic tolerance, we treated mice with a miR-142-regulated lentiviral vector encoding green fluorescent protein (GFP), and subsequently vaccinated the mice against GFP. In contrast to control mice, no anti-GFP response was observed, indicating that robust tolerance to the transgene-encoded antigen was achieved. Furthermore, injection of the miR-142-regulated vector induced a population of GFP-specific regulatory T cells. Interestingly, an anti-GFP response was observed when microRNA miR-122a was inserted into the vector and antigen expression was detargeted from hepatocytes as well as APCs. This demonstrates that, in the context of lentiviral vector-mediated gene transfer, detargeting antigen expression from professional APCs, coupled with expression in hepatocytes, can induce antigen-specific immunologic tolerance.
我们之前的研究表明,将造血特异性 microRNA miR-142 的靶序列整合到抗原编码转基因中,可以防止抗原在抗原呈递细胞 (APCs) 中表达。为了确定这种方法是否会诱导免疫耐受,我们用 miR-142 调控的慢病毒载体(编码绿色荧光蛋白 (GFP))处理小鼠,然后用 GFP 对小鼠进行疫苗接种。与对照组小鼠相比,未观察到抗 GFP 反应,表明成功地实现了对转基因编码抗原的强烈耐受。此外,miR-142 调控载体的注射诱导了一群 GFP 特异性调节性 T 细胞。有趣的是,当将 microRNA miR-122a 插入载体中并将抗原表达从肝细胞和 APC 中脱靶时,观察到抗 GFP 反应。这表明,在慢病毒载体介导的基因转移的情况下,从专业 APC 中脱靶抗原表达,同时在肝细胞中表达,可以诱导抗原特异性免疫耐受。